FDA Brief

Warning letters Drugs

FDA warning letter to

MB Solutions, LLC/BioSpectrum CBD

High riskIssued Jul 22, 2021Posted Jul 29, 2021Center for Drug Evaluation and Research

FDA warned BioSpectrum CBD over unapproved CBD nasal sprays, roll-on, edibles, and dog products sold online.

What happened

FDA reviewed www.biospectrumcbd.com, www.nasadol.com, and social media from April 2021 through July 2021. It found CBD nasal sprays, a pain relief roll-on, CBD edibles and tincture, and canine CBD products marketed with drug claims. FDA said these are unapproved new drugs, misbranded drugs, and adulterated foods or animal drugs.

What FDA found

  1. The CBD nasal sprays and pain relief roll-on are new drugs without FDA approval because the websites claim they treat pain, anxiety, depression, and other conditions.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  2. The Pain Relief Roll-On is misbranded because it is an over-the-counter drug that does not meet the legal requirements for marketing without an approved drug application.

    FD&C Act section 502(ee), 21 U.S.C. 352(ee)
  3. The CBD nasal sprays are misbranded because their labeling lacks adequate directions for use for conditions a layperson cannot safely self-diagnose and treat.

    FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1)
  4. The CBD gummies, peach rings, watermelon slices, and oil tincture are adulterated foods because CBD is an unsafe food additive that is not approved or generally recognized as safe.

    FD&C Act section 402(a)(2)(C)(i), 21 U.S.C. 342(a)(2)(C)(i)
  5. Adding CBD to food is a prohibited act under the FD&C Act.

    FD&C Act section 301(ll), 21 U.S.C. 331(ll)
  6. The canine CBD oil and CBD dog treats are unapproved new animal drugs and are adulterated because they are not approved or index listed by FDA.

    FD&C Act sections 512(a) and 501(a)(5), 21 U.S.C. 360b(a) and 351(a)(5)

What FDA wants

FDA tells the company to stop introducing these unapproved or misbranded drugs and adulterated foods into interstate commerce and to correct the violations. The provided letter does not state a response deadline.

Who should pay attention

  • retailers and distributors selling CBD nasal sprays or roll-ons
  • CBD edible and pet supplement brands
  • companies making drug-like claims for CBD products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk